GlassScriptPhysician profile
William S Cooley
NPI 1205849650
$1,676.51
in general payments reported to CMS, 2019-2025
16 companies · $93.19 in 2025
The $93.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $231 · 2021: $367 · 2022: $274 · 2023: $278 · 2024: $314 · 2025: $93.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.86 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $732.29 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $283.63 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $170.39 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $94.34 | 2023-2025 | Myfembree, Gemtesa |
| Abbott Laboratories | $92.37 | 2024 | Proclaim |
| Myovant Sciences INC. | $70.29 | 2022 | |
| Coloplast Corp | $57.71 | 2021 | |
| Novo Nordisk INC | $31.53 | 2024-2025 | Wegovy |
| Avion Pharmaceuticals | $27.69 | 2019-2021 | |
| Axonics, INC. | $20.83 | 2020 | |
| Amgen INC. | $18.69 | 2019 | |
| Boston Scientific Corporation | $17.52 | 2024 | Cre Pro |
| Agile Therapeutics, INC. | $16.34 | 2021 | |
| Mylan Pharmaceuticals INC. | $15.81 | 2020 | |
| Becton, Dickinson and Company | $13.76 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.